Compare GPK & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPK | PLSE |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.6B |
| IPO Year | 2007 | 2015 |
| Metric | GPK | PLSE |
|---|---|---|
| Price | $9.61 | $55.41 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 1 |
| Target Price | $13.08 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 4.8M | 568.0K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.58% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,617,000,000.00 | N/A |
| Revenue This Year | N/A | $840.00 |
| Revenue Next Year | $1.15 | $287.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.79 | $12.56 |
| 52 Week High | $20.44 | $58.90 |
| Indicator | GPK | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 33.75 | 66.89 |
| Support Level | $9.09 | $15.64 |
| Resistance Level | $10.02 | N/A |
| Average True Range (ATR) | 0.37 | 4.07 |
| MACD | -0.18 | -0.20 |
| Stochastic Oscillator | 15.06 | 68.88 |
Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Americas Paperboard Packaging, and International Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company operates in Americas, Europe and Asia Pacific regions.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.